J. Bash

发表

Vaccinia virus oncolysates in the treatment of malignant melanoma.

M. Wallack, J. Bash, 1988, Cancer treatment and research.

Kinetic study of T lymphocytes after sensitization against soluble antigen. III. Potentiation and suppression of the PHA response by antigen-activated lymphocytes of low density

H. Durkin, B. Waksman, J. Bash, 1975, The Journal of experimental medicine.

A search for markers of rabbit lymphoid cells; alloantigens characterized by antisera to rabbit thymus.

B. Cinader, S. Dubiski, J. Bash, 1974, International archives of allergy and applied immunology.

Cellular immunosenescence in F344 rats: Decreased natural killer (NK) cell activity involves changes in regulatory interactions between NK cells, interferon, prostaglandin and macrophages

J. Bash, D. Vogel, 1984, Mechanisms of Ageing and Development.

Cellular immunosenescence in F344 rats: Decline in responsiveness to phytohemagglutini involves changes in both T cells and macrophages

J. Bash, 1983, Mechanisms of Ageing and Development.

Phenotypic analysis of a human hematopoietic cell line with lymphoid and myeloid features using simultaneous multicolor flow cytometry.

D. A. Russo, C. August, J. Bash, 1997, Transplantation proceedings.

3‐Deazaadenosine, a transmethylase inhibitor, suppresses the effect of lipopolysaccharide on release of prostacyclin and thromboxane

J. Woody, P. Ramwell, N. Feuerstein, 1981, The Journal of pharmacy and pharmacology.

Leukotriene C stimulates prostaglandin release from rat peritoneal macrophages.

J. Woody, P. Ramwell, N. Feuerstein, 1981, Biochemical and biophysical research communications.

Treatment of murine hepatic metastases with vaccinia colon oncolysates and IL-2.

S. Hilsenbeck, M. Wallack, H. Iwaki, 1988, The Journal of surgical research.

Parallel orders of reactivity in murine cells of mezerein and phorbol esters toward the mixed-lymphocyte response and promotion of tumorigenesis.

C. Baxter, J. Bash, L. A. Fish, 1981, Toxicology and applied pharmacology.

The suppressive effect of immunization on the proliferative responses of rat T cells in vitro. II. Abrogation of antigen-induced suppression by selective cytotoxic agents.

A. Singer, B. Waksman, J. Bash, 1976, Journal of immunology.

A southeastern cancer study group phase I/II trial with vaccinia melanoma oncolysates

H. Wanebo, H. Seigler, A. Bartolucci, 1986, Cancer.

Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon α in a murine hepatic metastasis model

M. Wallack, J. Bash, P. J. Arroyo, 1990, Cancer Immunology, Immunotherapy.

Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate.

K. Bland, C. Balch, H. Wanebo, 1987, Archives of surgery.

Studies on allotypes in sheep.

F. Milgrom, J. Bash, 1972, International archives of allergy and applied immunology.

PHASE I TRIAL OF IMMUNOMODULATORY ACTIVITIES OF HUMAN LEUKOCYTE INTERFERON IN ADVANCED CANCER PATIENTS

J. Woody, J. Neefe, J. Bash, 1982 .

Murine lymphocyte comitogenesis by phorbol esters, and its inhibition by retinoic acid and inhibitors of polyamine biosynthesis.

C. Baxter, J. Bash, L. A. Fish, 1981, Toxicology and applied pharmacology.

Immunoregulation of Heymann's nephritis. I. Induction of suppressor cells.

E. Hess, A. Litwin, L. Adams, 1979, Journal of immunology.

A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO).

C. Balch, H. Wanebo, A. Bartolucci, 1986, The American surgeon.

Melanoma patient antibody responses to melanoma tumor-associated antigens defined by murine monoclonal antibodies.

H. Seigler, K. M. Roberson, M. Wallack, 1989, Journal of biological response modifiers.

Immunomodulatory activities of human leukocyte interferon in advanced cancer patients.

D. Teitelbaum, J. Neefe, J. Bash, 1983, Journal of biological response modifiers.

The effect of treatment withCorynebacterium parvum on the development and growth of experimental hematogenic metastases of schwannoma in the rat

W. Ritschel, T. Mandybur, J. Bash, 2004, Acta Neuropathologica.

Monoclonal antibodies to the cell surface of a unique human lymphoid/myeloid cell line detect epitopes absent from peripheral blood mononuclear cells.

D. A. Russo, C. August, J. Bash, 1997, Transplantation Proceedings.

Vaccinia virus‐infected C‐C36 colon tumor cell lysates stimulate cellular responses in vitro and protect syngeneic balb/c mice from tumor cell challenge

M. Wallack, H. Iwaki, J. Bash, 1989, Journal of Surgical Oncology.

Separation of T cell subpopulations capable of DNA synthesis, lymphotoxin release, and regulation of antigen and phytohemagglutinin responses on the basis of density and adherence properties.

H. Durkin, B. Waksman, J. Bash, 1975, Proceedings of the National Academy of Sciences of the United States of America.

SUPPRESSOR AND HELPER EFFECTS OF SENSITIZED T-CELL SUBPOPULATIONS ON PROLIFERATIVE T-CELL RESPONSES1

H. Durkin, B. Waksman, J. Bash, 1975 .

Recombinant vaccinia interleukin-2-infected tumor cell vaccines in immunotherapy of murine colon adenocarcinoma.

J. Bash, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

The suppressive effect of immunization on the proliferative responses of rat T cells in vitro.

B. Waksman, J. Bash, 1975, Journal of immunology.